Cyto-Facto Inc.
PrivateLast Round
Series B
Jun 13, 2025
Total Funding Raised
$18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cyto-Facto Inc. is a biotechnology company that provides contract development and manufacturing (CDMO) services for gene and cell therapy solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Vertical SaaS, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyto-Facto Inc. Comparables
Compare Cyto-Facto Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nikon | 76% | |
| Hitachi | 73% | |
| Teijin Limited | 70% |
Cyto-Facto Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2025 | ||||
| Series A | Apr 22, 2024 | ||||
| Seed | Aug 28, 2023 |
Cyto-Facto Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kobe University Capital | Series A |
| Mizuho Capital | Series A |
| MPower Partners | Series B, Series A |
| Sumitomo Corporation | Series B |
| Mitsubishi Corporation | Series A |
| SMBC Venture Capital | Series A |
| Fujifilm Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 104% MoM, reaching 4.7K.
Cyto-Facto Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cyto-Facto Inc.'s valuation, stock price, and market status.
Is Cyto-Facto Inc. a public or private company?
Cyto-Facto Inc. is a private company.
What is the current stock price of Cyto-Facto Inc.?
Cyto-Facto Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Cyto-Facto Inc. worth (valuation)?
Valuation information for Cyto-Facto Inc. is not publicly available.
Can I buy Cyto-Facto Inc. stock?
Cyto-Facto Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cyto-Facto Inc.'s last funding round?
Cyto-Facto Inc.'s most recent funding round was Series B on June 13, 2025.
Who are the main investors in Cyto-Facto Inc.?
Key investors in Cyto-Facto Inc. include MPower Partners, Fujifilm Corporation, D3 LLC.
Will Cyto-Facto Inc. IPO soon?
No public IPO plans have been announced for Cyto-Facto Inc..
How can I track Cyto-Facto Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cyto-Facto Inc.'s secondary market activity and sign up for updates.